Chenghui Pharmaceutical Group Co., Ltd. Founded in 2002 and headquartered in Jinan, Shandong, it is a high-tech enterprise with over 20 years of experience in the pharmaceutical industry. We have built a complete operational system integrating R&D, manufacturing, customization and sales. Our business scope covers high-end APIs, customized advanced pharmaceutical intermediates, full-cycle CDMO services, FDF formulation technology transfer and veterinary raw materials. We provide one-stop global registration solutions, and our products are marketed in more than 60 countries and regions worldwide.
The Group features a sound industrial layout: one core R&D center (Shandong Chenghui Blue Ocean Pharmaceutical Technology Co., Ltd.), one international API production base (Shandong Chenghui Shuangda Pharmaceutical Co., Ltd.), and two pharmaceutical intermediate production bases. Equipped with 9 GMP-compliant production lines, we achieve an annual output of over 3,000 tons and support flexible production ranging from gram to ton scale. Supported by the cGMP R&D platform and professional quality control center, we excel in chiral synthesis, crystal form control and high-risk complex synthesis, with full capabilities for process development, pilot scale-up and industrial production. Our manufacturing processes are in compliance with international standards including US-FDA, CEP and GMP.
We hold a total of 190 patents, among which 116 are granted, reflecting our strong R&D and innovation strength. Upholding the tenet of "Integrity First, Open Cooperation, Innovation Leading", we strive to deliver professional and reliable pharmaceutical products and services to global customers.
